A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia

NCT01568333 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Immune Thrombocytopenia

Interventions

DRUG: Decitabine

Sponsor

Shandong University

Collaborators

[object Object]
[object Object]